title: Life-threatening adverse event after amphotericin B lipid complex treatment in a patient treated previously with amphotericin B deoxycholate.
authors.affiliation: Intensive Care Unit, Hospital Universitario Virgen Del Rocio, Seville, Spain.
authors.forename: J
authors.initials: J
authors.lastname: Garnacho-Montero
authors.forename: C
authors.initials: C
authors.lastname: Ortiz-Leyba
authors.forename: J L
authors.initials: JL
authors.lastname: García Garmendia
authors.forename: F
authors.initials: F
authors.lastname: Jiménez Jiménez
mesh_terms: D000666:Amphotericin B / Q000009:adverse effects* / Q000627:therapeutic use*; D000935:Antifungal Agents / Q000009:adverse effects* / Q000627:therapeutic use; D002177:Candidiasis / Q000150:complications* / Q000188:drug therapy; D003840:Deoxycholic Acid / Q000627:therapeutic use*; D004338:Drug Combinations; D006801:Humans; D008297:Male; D008875:Middle Aged; D010713:Phosphatidylcholines / Q000009:adverse effects* / Q000627:therapeutic use; D010715:Phosphatidylglycerols / Q000009:adverse effects* / Q000627:therapeutic use; D012120:Respiration Disorders / Q000139:chemically induced*
chemical_list: D000935:Antifungal Agents; D004338:Drug Combinations; D010713:Phosphatidylcholines; D010715:Phosphatidylglycerols; C068538:liposomal amphotericin B; D003840:Deoxycholic Acid; D000666:Amphotericin B; C059765:amphotericin B, deoxycholate drug combination